Polydex Pharmaceuticals Ltd (POLXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Sales | 945 | 1,096 | 1,341 | 847 | 1,410 |
| Cost of Goods | 965 | 976 | 1,211 | 824 | 1,093 |
| Gross Profit | -20 | 121 | 130 | 23 | 317 |
| Operating Expenses | 1,136 | 1,165 | 374 | 1,042 | 345 |
| Operating Income | -191 | -69 | -33 | -195 | 65 |
| Interest Expense | 5 | 13 | 9 | 10 | 10 |
| Other Income | 5 | 13 | 9 | 10 | 10 |
| Pre-tax Income | -191 | -69 | -33 | -195 | 65 |
| Net Income Continuous | -255 | -69 | -33 | -195 | 65 |
| Net Income | $-255 | $-69 | $-33 | $-195 | $65 |
| EPS Basic Total Ops | -0.07 | -0.02 | -0.01 | -0.06 | 0.01 |
| EPS Basic Continuous Ops | -0.07 | -0.02 | -0.01 | -0.06 | 0.02 |
| EPS Diluted Total Ops | -0.07 | -0.02 | -0.01 | -0.06 | 0.01 |
| EPS Diluted Continuous Ops | -0.07 | -0.02 | -0.01 | -0.06 | 0.02 |
| EPS Diluted Before Non-Recurring Items | -0.07 | -0.02 | -0.01 | N/A | N/A |
| EBITDA(a) | $-103 | $27 | $60 | $-105 | $154 |